bf/NASDAQ:AYTU_icon.png

NASDAQ:AYTU

Aytu BioPharma, Inc.

  • Stock

USD

Last Close

3.31

14/05 17:39

Market Cap

15.87M

Beta: −0.41

Volume Today

18.41K

Avg: 68.94K

PE Ratio

−0.52

PFCF: 3.71

Aug '13
Aug '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
revenue
1.75K
-
58.93K
3,267.37%
261.78K
344.23%
2.56M
878.85%
3.22M
25.72%
3.66M
13.61%
7.32M
100.01%
27.63M
277.47%
65.63M
137.52%
96.67M
47.29%
107.40M
11.10%
cost of revenue
-48.25K
-
88.11K
-
957.08K
986.24%
1.42M
48.09%
2.05M
44.67%
2.20M
7.39%
7.55M
243.00%
36.43M
382.35%
44.39M
21.83%
40.77M
8.15%
gross profit
50K
-
58.93K
17.86%
173.67K
194.72%
1.61M
824.36%
1.80M
12.39%
1.61M
10.80%
5.12M
218.02%
20.08M
292.30%
29.20M
45.43%
52.28M
79.05%
66.63M
27.44%
selling and marketing expenses
-242
-
11.40M
-
30.31M
165.79%
38.71M
27.73%
41.45M
7.06%
general and administrative expenses
47.98K
-
2.35M
4,790.29%
4.38M
86.77%
8.83M
101.37%
17.61M
99.52%
17.73M
0.70%
19.66M
-
25.50M
29.72%
31.17M
22.22%
28.63M
8.14%
selling general and administrative expenses
47.98K
-
2.35M
4,790.29%
4.38M
86.77%
8.83M
101.37%
17.61M
99.51%
17.73M
0.71%
19.24M
8.50%
34.80M
80.89%
55.81M
60.36%
69.88M
25.22%
70.08M
0.28%
research and development expenses
2.76M
-
4.06M
47.29%
3.42M
15.66%
6.32M
84.61%
1.35M
78.67%
167.59K
87.57%
589.07K
251.49%
1.72M
192.23%
5.62M
226.65%
14.44M
156.78%
4.09M
71.64%
other expenses
6.18K
-
6.18K
0%
4.89K
20.87%
664.71K
13,493.19%
1.71M
157.07%
6.28M
267.39%
2.14M
65.97%
4.49M
110.20%
6.01M
33.82%
4.07M
32.32%
-4.78M
217.51%
cost and expenses
54.16K
-
6.41M
11,726.61%
7.89M
23.23%
16.77M
112.40%
22.08M
31.70%
21.50M
2.62%
24.17M
12.38%
48.57M
100.97%
103.87M
113.87%
132.77M
27.82%
119.73M
9.82%
operating expenses
54.16K
-
6.41M
11,726.61%
7.81M
21.86%
15.81M
102.53%
20.66M
30.71%
19.45M
5.86%
21.96M
12.91%
41.01M
86.73%
67.44M
64.43%
88.39M
31.06%
78.96M
10.66%
interest expense
4.90K
-
45.55K
828.89%
114.99K
152.44%
5.49M
4,675.45%
2.53M
53.85%
749.42K
70.43%
147.50M
-
ebitda
-47.47K
-
-6.25M
13,064.30%
-7.51M
20.24%
-13.33M
77.39%
-14.50M
8.75%
-8.98M
38.08%
-4.37M
51.31%
-24.61M
463.20%
-14.49M
41.12%
41.28M
384.88%
-7.60M
118.41%
operating income
-52.41K
-
-6.35M
12,009.04%
-7.63M
20.25%
-21.70M
184.37%
-20.13M
7.28%
-19.70M
2.11%
-16.85M
14.49%
-20.94M
24.27%
-38.24M
82.66%
37.22M
197.32%
-17.07M
145.86%
depreciation and amortization
4.94K
-
97.48K
1,872.40%
118.20K
21.26%
874.79K
640.08%
4.36M
398.94%
2.59M
40.63%
12.48M
381.50%
-3.68M
129.46%
23.75M
746.19%
4.07M
82.88%
4.79M
17.73%
total other income expenses net
219
-
-45.55K
20,900.46%
-114.99K
152.44%
-8.48M
7,277.95%
-1.11M
86.87%
8.41M
854.67%
-10.29M
222.36%
7.31M
171.12%
-19.79M
370.56%
-147.50M
645.32%
-4.72M
96.80%
income before tax
-57.32K
-
-6.39M
11,052.49%
-7.75M
21.20%
-28.18M
263.74%
-22.51M
20.13%
-10.19M
54.74%
-27.13M
166.32%
-13.62M
49.80%
-58.03M
326.04%
-110.28M
90.04%
-17.05M
84.54%
income tax expense
911.30K
-
-813.70K
189.29%
-23.91K
97.06%
8.48M
35,583.90%
1.11M
86.87%
-2.13M
291.04%
20.04M
1,041.54%
-9.92M
149.52%
259K
102.61%
-110K
142.47%
-57K
48.18%
net income
-57.32K
-
-5.58M
9,632.88%
-7.72M
38.44%
-28.18M
264.87%
-22.51M
20.13%
-10.19M
54.74%
-47.17M
362.97%
-3.70M
92.16%
-58.29M
1,475.55%
-110.17M
89.01%
-17.05M
84.52%
weighted average shs out
8
-
9
12.50%
38.97K
-
225.96K
479.80%
837.33K
270.57%
73.49K
91.22%
3.34M
4,444.52%
weighted average shs out dil
8
-
9
12.50%
38.97K
-
225.96K
479.80%
837.33K
270.57%
73.49K
91.22%
3.34M
4,444.52%
eps
-7.16K
-
-619.85K
8,551.45%
-1.21K
-
-16.37
98.65%
-69.61
325.23%
-1.50K
2,053.57%
-5.11
99.66%
epsdiluted
-7.16K
-
-619.85K
8,551.45%
-1.21K
-
-16.37
98.65%
-69.61
325.23%
-1.50K
2,053.57%
-5.11
99.66%

All numbers in USD (except ratios and percentages)